Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, et al. SPINK1 protein expression and prostate cancer progression. Clin Cancer Res. 2014;20(18):4904-11.

Park K, Chen Z, MacDonald TY, Siddiqui J, Ye H, Erbersdobler A, et al. Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification. Hum Pathol. 2014;45(10):2136-43.

Lohr JG, Adalsteinsson VA, Cibulskis K, Choudhury AD, Rosenberg M, Cruz-Gordillo P, et al. Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer. Nat Biotechnol. 2014;32(5):479-84.

Perkins J, Scarbrough C, Sammons D, Magro C. Reed syndrome: an atypical presentation of a rare disease. Dermatol Online J. 2014;21(3).

Kiuru M, Schwartz M, Magro C. Cutaneous thrombogenic vasculopathy associated with bevacizumab therapy. Dermatol Online J. 2014;20(6).

Kim D-, Rhee I, Paik J. Metabolic circuits in neural stem cells. Cell Mol Life Sci. 2014;71(21):4221-41.

Galletti G, Matov A, Beltran H, Fontugne J, Mosquera JM, Cheung C, et al. ERG induces taxane resistance in castration-resistant prostate cancer. Nat Commun. 2014;5:5548.

Lonze BE, Zachary AA, Magro CM, Desai NM, Orandi BJ, Dagher NN, et al. Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. Am J Transplant. 2014;14(2):459-65.

Marzio A, Merigliano C, Gatti M, Vernì F. Sugar and chromosome stability: clastogenic effects of sugars in vitamin B6-deficient cells. PLoS Genet. 2014;10(3):e1004199.

Kim SY, Baik K-, Baek K-, Chah K-, Kim KA, Moon G, et al. S6K1 negatively regulates TAK1 activity in the toll-like receptor signaling pathway. Mol Cell Biol. 2014;34(3):510-21.